AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

CRANEWARE PLC

Remuneration Information Mar 9, 2016

7581_dirs_2016-03-09_a001f0ef-7164-4026-8c58-1661d15edef9.html

Remuneration Information

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 4746R

Craneware plc

09 March 2016

Craneware plc

("Craneware", "the Group" or the "Company")

Grant of Options

9 March 2016 - The Board of Craneware plc (AIM: CRW.L), the market leader in Value Cycle solutions for the US healthcare market, announces that on 8 March 2016, the Remuneration Committee approved the granting of share options to certain Directors to subscribe for ordinary shares of 1p each in the Company as follows:

Director No. of options granted Percentage of issued share capital
Keith Neilson (CEO) 28,628 0.11
Craig Preston (CFO) 26,925 0.10

The above options have been granted at an exercise price of 750p per share (being the closing market price on 8 March 2016). These options will be subject to performance criteria, such that they vest in three equal tranches over three years. One third of the share options will vest on or after 30 June 2016, one third on or after 30 June 2017 and the final third on or after 30 June 2018. The share options will not become exercisable until three years from the date of the grant.

For further information, please contact:

Craneware plc Peel Hunt Alma
+44 (0)131 550 3100 +44 (0)20 7418 8900 +44 (0)208 004 4218
Keith Neilson, CEO Dan Webster Caroline Forde
Craig Preston, CFO Richard Kauffer Hilary Buchanan

About Craneware

Craneware is the leader in automated value cycle solutions that help US provider organisations discover, convert and optimise assets to achieve best clinical outcomes and financial performance. Founded in 1999, Craneware has headquarters in Edinburgh, Scotland with offices in Atlanta, Boston and Phoenix employing over 200 staff. Craneware's market-driven, SaaS solutions normalise disparate data sets, bringing in up-to-date regulatory and financial compliance data to deliver value at the points where clinical and operational data transform into financial transactions, creating actionable insights that enable informed tactical and strategic decisions. To learn more, visit craneware.com and thevaluecycle.com.

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSEAADPEFAKEAF

Talk to a Data Expert

Have a question? We'll get back to you promptly.